Evidence map›Paper›PMID 28264674›Full record

ArticleVirology journal2017

Epstein-Barr virus and cytomegalovirus infections and their clinical relevance in Egyptian leukemic pediatric patients.

Samah Aly Loutfy, Maha A Abo-Shadi, Mohamed Fawzy, Mohamed El-Wakil, Shimaa A Metwally, Manar M Moneer, Nasra F Abdel Fattah, Sara Kassem, Ahmed Elgebaly

Open access · goldAbstract read
In one paragraph

Article in Virology journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Samah Aly LoutfyVirology and Immunology Unit, Cancer Biology Department, National Cancer Institute, Cairo University, Fom El-Khalig, Cairo, 11796, Egypt. samaly183@yahoo.com.
Maha A Abo-ShadiMicrobiology and Immunology Department, Faculty of Pharmacy (Girls), Al Azhar University, Nasr City, Egypt.
Mohamed FawzyPediatric Oncology Department, National Cancer Institute, Cairo University, Cairo, Egypt.
Mohamed El-WakilClinical Oncology Department, Faculty of Medicine, Beni-Suef University, Beni Suef, Egypt.
Shimaa A MetwallyMicrobiology and Immunology Department, Faculty of Pharmacy (Girls), Al Azhar University, Nasr City, Egypt.
Manar M MoneerCancer Epidemiology and Biostatistics Department, National Cancer Institute, Cairo University, Cairo, Egypt.
Nasra F Abdel FattahVirology and Immunology Unit, Cancer Biology Department, National Cancer Institute, Cairo University, Fom El-Khalig, Cairo, 11796, Egypt.
Sara KassemChemistry of natural and microbial products Department Pharmaceutical Industries Division, National Research Center, Giza, Egypt.
Ahmed ElgebalyFaculty of Medicine, Al Azhar University, Nasr City, Egypt.
Al-Azhar University · EGCairo University · EGBeni-Suef University · EGChildren Cancer Hospital · EGNational Research Centre · EG

Funding

Role of LANA-RBP-jk During Early KSHV InfectionP01CA174439 · NCI · UNIVERSITY OF PENNSYLVANIA · PI ROBERTSON, ERLE S. · 2013 to 2018
$8.7M
Genome Persistence of KSHVR01CA171979 · NCI · UNIVERSITY OF PENNSYLVANIA · PI ROBERTSON, ERLE S. · 2013 to 2017
$1.5M
KSHV genome modification in KS tissueR01CA177423 · NCI · UNIVERSITY OF PENNSYLVANIA · PI ROBERTSON, ERLE S. · 2013 to 2015
$594k
NCI NIH HHS P01 CA174439NCI NIH HHS R01 CA171979NCI NIH HHS R01 CA177423
6 · The paper itself

Abstract

backgroundEpstein-Barr virus (EBV) and human cytomegalovirus (CMV) infections are environmental risk factors affecting the outcome of cancer due to an impairment in the cell-mediated immunity. Therefore, this study aimed to detect the frequency of EBV and CMV DNA and their association with clinical characteristics and outcome of pediatric leukemic patients.

methodsSamples of 50 immunocompromised pediatric leukemic patients and 30 apparently healthy children were subjected to the amplification of EBV DNA by one version of PCR targeting the Bam H1 W region of the genomic region of EBV, and the amplification of CMV DNA by targeting the CMV UL97 genomic region by a second round PCR. All investigations were performed on WBCs and sera. Results were correlated with the clinical and laboratory characteristics of the disease, and with overall survival.

resultsEBV and CMV DNA were detected in 20 and 54% of leukemic patients, respectively. Nine out of ten patients with EBV DNA (90%) were positive for CMV DNA in their sera. The presence of EBV DNA or CMV DNA was associated with neutropenia and a low total leukocyte count (TLC) (p = 0.02, 0.03, respectively). The presence of severe CMV disease, longer duration of febrile neutropenia, neutropenia, lymphopenia, thrombocytopenia and the presence of EBV DNA in patients' sera were significantly associated with worse overall survival.

conclusionThe detection of CMV disease and EBV DNA is relatively common in leukemic children and is significantly associated with a decline in the overall survival.

Indexed as

AdolescentChildChild, PreschoolCytomegalovirusCytomegalovirus InfectionsDNA, ViralEgyptEpstein-Barr Virus InfectionsFemaleHerpesvirus 4, HumanHumansImmunocompromised HostInfantLeukemiaMalePolymerase Chain ReactionDNA, ViralCMVEBVPCRPediatric leukemiaSurvival

Identifiers

PMID28264674
PMCPMC5339968
OpenAlexW2593256495

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.